| 英文别名 |
Saxagliptin hydrochloride;(1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrochloride;SAXAGLIPTIN HCL;Saxagliptin HCL salt;(1S,3S,5R)-2-[(2S)-2-Amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;Saxagliptin Hydrochloride;SAXAGLIPTIN HYDROCHLORIDE [VANDF];SCHEMBL15152103;Q27295146;709031-78-7;2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, hydrochloride (1:1), (1S,3S,5S)-; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, monohydrochloride, (1S,3S,5S)- (9CI); Saxagliptin hydrochloride;SAXAGLIPTIN HYDROCHLORIDE COMPONENT OF KOMBIGLYZE;SAXAGLIPTIN HYDROCHLORIDE [MART.];SAXAGLIPTIN HYDROCHLORIDE [ORANGE BOOK];KOMBIGLYZE COMPONENT SAXAGLIPTIN HYDROCHLORIDE;DS-8019;SAXAGLIPTIN HYDROCHLORIDE COMPONENT OF QTERN;QTERN COMPONENT SAXAGLIPTIN HYDROCHLORIDE;SAXAGLIPTIN HYDROCHLORIDE COMPONENT OF QTERNMET XR;(1S,3S,5S)-2-[(2S)-Amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrochloride;2-Azabicyclo[3.1.0]hexane-3-carbonitrile,2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-,monohydrochloride, (1S,3S,5S)-;SAXAGLIPTIN HYDROCHLORIDE [WHO-DD];(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;hydrochloride;C18H26ClN3O2;TUAZNHHHYVBVBR-NHKADLRUSA-N;AKOS025290185;D10262;CS-0006342;Saxagliptin HCl;QTERNMET XR COMPONENT SAXAGLIPTIN HYDROCHLORIDE;Z8J84YIX6L;SAXAGLIPTIN HYDROCHLORIDE (MART.);(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrochloride;DTXSID50991191;CHEMBL1201743;UNII-Z8J84YIX6L;EN300-26976214;Onglyza (TN);Onglyza;Saxagliptin (hydrochloride);HY-16448 |
微信公众号
客服
